December 19, 2019 feature
Iron selenide quantum dots for in vivo multiphoton biomedical imaging
Photoluminescent probes with high biocompatibility, quantum yield and multiphoton absorption performance are of significant interest in biomedical imaging, expected to achieve improved penetration depth and spatial resolution. Iron selenide (FeSe) quantum dots (QDs) are reported to meet these criteria based on a new report published in Science Advances by J. Kwon and a team of researchers in the interdisciplinary departments of Chemistry, Biomaterial Science and Cogno-Mechantronics Engineering in Korea and China. Quantum dots are nanometer-scale luminescent semiconductor crystals with unique chemical and physical properties relative to their structure and composition.
The synthetic QDs in the present study can exhibit two- and three-photon excitation properties at 800- and 1800 nm wavelengths with a high quantum yield (40 percent) for second-window imaging. The materials were also biocompatible and verified by Kwon et al. when they linked poly(ethylene glycol)-conjugated QDs with human epidermal growth factor receptor 2 (HER2) antibodies for in vitro and in vivo two-photon imaging. The scientists successfully imaged the surfaces at a depth of up to 500 µm from the surface of skin using a nonlinear femtosecond laser at an excitation wavelength of 800 nm. The findings can open a new path to use biocompatible FeSe QDs for multiphoton tissue imaging during disease diagnosis.
Transition metal chalcogenides are attractive across a range of research areas in nanoscience with applications as magnetic semiconductors, superconductors, photovoltaics, electrocatalysts, sensors and quantum dots. Layered iron-based materials are promising superconductor candidates with low toxicity and cost, with unexpectedly high superconducting transition temperature. Iron chalcogenide materials can become fluorescent nanosemiconductors when their dimensions reduce to zero. These have unique optoelectronic properties relevant in biological imaging and solar power conversion. Fluorescent biomedical imaging with semiconducting nanocrystals are a promising detection technique due to high photostability and tunability of the nanocrystals during absorption and emission spectra compared to conventional organic dyes. QDs can also exhibit multiphoton-excited photoluminescence (PL) where a luminophore can simultaneously absorb more than two photons via a virtual state to emit visible light.
The phenomenon can allow greater penetration depth for reduced tissue autofluorescence and scattering with benefits for in situ biomedical fluorescence imaging during cancer surgery. Scientists therefore view multiphoton microscopy (MPM) as a non-invasive, in vivo, deep-tissue imaging tool. In the present study, Kwon et al. were motivated by preceding work to synthesize biocompatible QDs with two- and three-photon luminescent properties using iron (Fe) and selenium (Se) elements. In general, the two (Fe and Se precursors) naturally occur in the human body and exhibit low toxicity in nanoparticle form. The research team tested in vitro tumor cell targeting specificity with humanized monoclonal HER2 (human epidermal growth factor receptor 2) antibody—conjugated iron selenide (FeSe) quantum dots (anti-HER2-QDs). For the in vitro experiments, they used a HER2-overexpressed MCF-7 (Michigan Cancer Foundation) xenograft model (grafts from a different donor species) of breast cancer cell line. They then conducted in vivo MPM (multiphoton microscopy) imaging within a live xenograft model of human breast tumor.
To develop the water-soluble FeSe QDs, the scientists used a one-pot synthetic strategy. They formed QDs approximating 3.4 ± 0.3 nm in size and observed them using bright-field transmission electron microscopy (TEM). Using high-resolution TEM and electron diffraction patterns of QDs, they observed the plane of tetragonal FeSe. The scientists used structural analysis with a grazing incidence X-ray diffraction spectrometer (GIXRD) and X-ray photoelectron spectroscopy to meticulously prove the morphology of FeSe QDs. Zeta potential tests showed that FeSe QDs dissolved in deionized water and in 0.01 M as well as 0.1 M phosphate-buffer (PBS) saline. When Kwon et al. monitored them using a digital camera and fluorescent microscopy after five days, the QDs did not aggregate or differ in fluorescence. The bandgap of FeSe QDs approximated 2.44 eV from the ultraviolet to visible (UV-Vis) spectrum.
Kwon et al. explored the photoluminescence (PL) properties of FeSe QDs at 25 degrees C to observe a lifetime of 3.23 nanoseconds (ns). They noted a two-photon (2PL) and three-photon (3PL) excited PL, followed by representative fluorescence microscopic images of MCF27 cells stained with FeSe QDs from 2PL and 3PL. This multiphoton excitation property is notable for bioimaging with a longer wavelength that can penetrate a maximum tissue depth with reduced phototoxicity, observed within the "golden window" during brain tissue imaging.
The research team first tested QD influence on cell viability before applying FeSe QDs to bioimaging experiments. They used different cell lines cultured with diverse concentrations of FeSe QDs at various culture durations and observed excellent viability by seven days, with >75 percent cell viability. Using fluorescence microscopic images of the cell cultures, Kwon et al. recorded the superior biocompatibility of FeSe QDs, where the quantum dots did not interfere with cell growth. To further minimize nonspecific binding during the assembly, the scientists encapsulated FeSe QDs with poly(ethylene glycol) (PEG) before conjugation with HER2 antibodies to develop anti-HER2-PEG-QDs.
The team tested the nonspecific uptake and selectivity of the conjugates during human breast cancer cell targeting via propidium iodide staining. The anti-HER2-PEG-QDs specifically targeted the HER2 receptors, indicating the potential to use PEGylated QDs as imaging agents in vivo. The physiologically stable molecules maintained their optical properties for seven days in serum and in a variety of buffer solutions. The FeSe QDs were highly photostable during two-photon excitation with additional properties suited for biological imaging and long-term tracking of targeted cells.
The study offered a fresh perspective for breast cancer diagnosis. Breast cancer is the second-highest cause of cancer death for women, with significant recurrence rates, where minimally invasive surgery aided with sensing and imaging techniques are crucial to identify the disease. The research team established an in vivo MPM (multiphoton microscopy) imaging method with intravenous injection of anti-HER2-PEG-QDs in an MCF xenograft animal model. They then established a subcutaneous xenograft mouse model of breast cancer by injecting MCF7 cells and MCF/HER2 cells into the flank of mice. After four weeks, when the tumor volume reached 200 mm3, the scientists injected 100 µL of anti-HER2-PEG-QDs and observed the FeSe QDs as a magenta signal. They then obtained 2PL signals at different depths across the tumor area at regular intervals. The second harmonic generation (SHG) signal appeared blue to represent collagen in the superficial area and the scientists distinguished the PL signal from QDs near the breast cancer cells.
In this way, J. Kwon and colleagues synthesized biocompatible FeSe QDs with strong cell viability at increased QD concentrations. The team used QDs during two- and three-photon fluorescence imaging and with multiphoton imaging at a depth of up to 500 µm to monitor tumor cells with a nonlinear femtosecond laser within live animals in vivo. The combined biocompatible FeSe QDs and multiphoton imaging can open a new method to realize noninvasive in situ bioimaging within live subjects.
Wei Li et al. Phase separation and magnetic order in K-doped iron selenide superconductor, Nature Physics (2011). DOI: 10.1038/nphys2155
Xingyong Wu et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots, Nature Biotechnology (2003). DOI: 10.1038/nbt764
© 2019 Science X Network